The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
Abstract
BACKGROUND: We hypothesized that a high within-patient variability in clearance of tacrolimus and mycophenolate mofetil (MMF) would put patients at risk for periods of over- or underimmunosuppression and would thus lead to long-term chronic allograft nephropathy and graft loss after transplantation. METHODS: From 297 patients transplanted between 1 January 2000 and 31 December 2004, the within-patient variability in clearance was calculated from tacrolimus whole-blood concentrations and mycophenolic acid (MPA) plasma concentrations drawn between 6 and 12 months post-transplantation. As a primary outcome, a composite end point consisting of graft loss, biopsy-proven chronic allograft nephropathy and 'doubling in plasma creatinine concentration in the period between t = 12 months post-transplantation and last follow-up' was used. RESULTS: In the study population of 297 patients, 34 patients reached the primary end point of graft failure. The within-patient variability in the clearance of tacrolimus and three other covariates are significant risk factors for reaching the composite end point of failure [P-values for intraindividual tacrolimus variability = 0.003, biopsy-proven acute rejection (BPAR) = 0.003, recipient age at transplantation = 0.005]. The mean tacrolimus concentration for controls [7.4 (+/- 2.9) ng/mL] and for failures [6.9 (+/- 2.5) ng/mL] was similar. Within-patient variability in the clearance of MPA was not related to reaching the composite end point of failure. CONCLUSIONS: This study shows a significant relationship between the high within-patient variability in the clearance of tacrolimus, but not for MPA, and long-term graft failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
Staatz, C. E., & Tett, S. E. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443100-00001 · Cited by 913
Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients
Staatz, C. E., & Tett, S. E. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746010-00002 · Cited by 602
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
Kahan, B. D., Keown, P., Levy, G. A., & Johnston, A. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85038-x · Cited by 292
Kahan, B. D., Dunn, J., Fitts, C., Van Buren, D., Wombolt, D., Pollak, R., Carson, R., Alexander, W. J., Choc, M., Wong, R., et al. (1995) · Transplantation · doi:10.1097/00007890-199502270-00011 · Cited by 215
Kahan, B. D., Welsh, M. S., Urbauer, D. L., Mosheim, M. B., Beusterien, K. M., Wood, M., Schoenberg, L., DiCesare, J., Katz, S. M., & Buren, C. T. V. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1161122 · Cited by 89
Djebli, N., Rousseau, A., Hoizey, G., Rérolle, J.-P., Toupance, O., Meur, Y. L., & Marquet, P. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00007 · Cited by 77
Pharmacokinetic Principles of Immunosuppressive Drugs
Srinivas, T. R., Meier‐Kriesche, U., & Bruce, K. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00748.x · Cited by 68
The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated aging
Joosten, S. A., van Kooten, C., Sijpkens, Y. W. J., de Fijter, J. W., & Paul, L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.05410.x · Cited by 47
Hesse, C. J., Baan, C. C., Balk, A. H. M. M., Metselaar, H. J., Weimar, W., & van Gelder, T. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03510-8 · Cited by 31
Self-citation
Cited by
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
Brunet, M., van Gelder, T., Åsberg, A., Haufroid, V., Hesselink, D. A., Langman, L., Lemaitre, F., Marquet, P., Seger, C., Shipkova, M., et al. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000640 · Cited by 707
Self-citationAndrews, L. M., Li, Y., De Winter, B. C. M., Shi, Y.-Y., Baan, C. C., Van Gelder, T., & Hesselink, D. A. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1395413 · Cited by 142
Gallagher, H. M., Sarwar, G., Tse, T., Sladden, T. M., Hii, E., Yerkovich, S. T., Hopkins, P. M., & Chambers, D. C. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.028 · Cited by 51
Metadata
- Authors
- Borra, L. C. P., Roodnat, J. I., Kal, J. A., Mathot, R. A. A., Weimar, W., & van Gelder, T.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-26
- Volume
- 25
- Issue
- 8
- Pages
- 2757-2763
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2131745220
- Cited by
- 256
- References
- 9
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. https://app.cochat.ai/papers/10.1093/ndt/gfq096
- The paper
- Borra, L. C. P., Roodnat, J. I., Kal, J. A., Mathot, R. A. A., Weimar, W., & van Gelder, T. (2010). High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfq096
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.